Skip to content

Clinical trials

Carcinoma, Renal Cell trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: Singapore Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20073
20083
20101
20131
20153
20172
20182
20193
20201
20212
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated6
Active, not recruiting5
Recruiting2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Pfizer4
Hoffmann-La Roche3
Merck Sharp & Dohme LLC2
National University Hospital, Singapore2
AstraZeneca1
Bristol-Myers Squibb1
Coherus Oncology, Inc.1
Exelixis1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell29
Carcinoma, Non-Small-Cell Lung10
Kidney Neoplasms6
Melanoma6
Carcinoma5
Neoplasms5
Head and Neck Neoplasms4
Carcinoma, Hepatocellular3
Colorectal Neoplasms3
Ovarian Neoplasms3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.